NASDAQ:ABEO
Abeona Therapeutics Inc. Stock News
$3.26
+0.0700 (+2.19%)
At Close: Apr 26, 2024
NEW YORK, March 23, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary dut
Week 9 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge
07:20am, Sunday, 28'th Feb 2021
Week 9 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge
Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
07:30am, Monday, 22'nd Feb 2021
NEW YORK and CLEVELAND, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the company will present at
In addition to preservation of neurocognitive development with ABO-102 in MPS IIIA, new clinical results of ABO-102 in MPS IIIA and ABO-101 in MPS IIIB continue to show dose-dependent and sustained re
NEW YORK and CLEVELAND, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it will host a live webinar
Clinical trial amendment successfully completed for co-primary endpoints of partial wound closure and mean pain reduction Clinical trial amendment successfully completed for co-primary endpoints of
Do Options Traders Know Something About Abeona (ABEO) Stock We Don't?
09:47am, Tuesday, 12'th Jan 2021
Investors need to pay close attention to Abeona (ABEO) stock based on the movements in the options market lately.
NEW YORK and CLEVELAND, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that abstracts detailing new inte
Why This Abeona Therapeutics Analyst Is Turning Bullish After Q3 Print
11:24am, Wednesday, 11'th Nov 2020
Abeona Therapeutics Inc's (NASDAQ: ABEO) stock does not reflect the company's in-house manufacturing capabilities and pipeline, according to Cantor Fitzgerald. The Abeona Therapeutics Analyst: Kriste
Abeona Therapeutics Reports Third Quarter Financial Results
04:05pm, Monday, 09'th Nov 2020
Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET
Abeona Therapeutics Announces the Appointment of Michael Amoroso as Chief Operating Officer
06:30am, Tuesday, 27'th Oct 2020
NEW YORK and CLEVELAND, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Michael Amoroso, Senior Vice
OXGENE Introduces TESSA Technology for Robust and Reproducible AAV Manufacture at Scale
12:00am, Tuesday, 22'nd Sep 2020
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-
Abeona Therapeutics (ABEO) Investor Presentation - Slideshow
05:45pm, Friday, 11'th Sep 2020
The following slide deck was published by Abeona Therapeutics Inc. in conjunction with this event..
NEW YORK and CLEVELAND and DALLAS, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, and Taysha Gene Therapies, a patient-c
Genomic Medicine: Summer 2020 Update
09:36am, Thursday, 13'th Aug 2020
FDA approvals, new guidance statements, and RMAT requests all show the pace of genomics is accelerating.